Brandywine Global Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-218,649
Closed -$23.9M 779
2023
Q1
$23.9M Sell
218,649
-310,344
-59% -$33.9M 0.19% 132
2022
Q4
$60.2M Sell
528,993
-144,930
-22% -$16.5M 0.47% 57
2022
Q3
$41.7M Buy
+673,923
New +$41.7M 0.39% 74
2020
Q3
Sell
-79
Closed -$5K 793
2020
Q2
$5K Sell
79
-37,146
-100% -$2.35M ﹤0.01% 717
2020
Q1
$1.1M Sell
37,225
-927,602
-96% -$27.5M 0.01% 510
2019
Q4
$34.9M Sell
964,827
-119,125
-11% -$4.31M 0.25% 96
2019
Q3
$29.5M Buy
1,083,952
+973,669
+883% +$26.5M 0.22% 104
2019
Q2
$2.65M Sell
110,283
-1,063,265
-91% -$25.6M 0.02% 507
2019
Q1
$31M Sell
1,173,548
-313,599
-21% -$8.29M 0.21% 100
2018
Q4
$29.1M Sell
1,487,147
-991,051
-40% -$19.4M 0.22% 107
2018
Q3
$48.5M Sell
2,478,198
-444,512
-15% -$8.7M 0.3% 81
2018
Q2
$48.4M Sell
2,922,710
-824,097
-22% -$13.6M 0.31% 85
2018
Q1
$53.2M Sell
3,746,807
-413,667
-10% -$5.87M 0.34% 75
2017
Q4
$60.7M Buy
4,160,474
+149,854
+4% +$2.19M 0.36% 70
2017
Q3
$50.9M Buy
4,010,620
+51,818
+1% +$657K 0.32% 74
2017
Q2
$47M Buy
3,958,802
+428,546
+12% +$5.09M 0.3% 79
2017
Q1
$52.2M Buy
3,530,256
+1,038,483
+42% +$15.3M 0.33% 72
2016
Q4
$40.3M Sell
2,491,773
-152,985
-6% -$2.48M 0.26% 90
2016
Q3
$48M Sell
2,644,758
-164,624
-6% -$2.98M 0.32% 82
2016
Q2
$46.3M Buy
2,809,382
+340,618
+14% +$5.61M 0.31% 82
2016
Q1
$40.9M Buy
2,468,764
+198,244
+9% +$3.28M 0.27% 87
2015
Q4
$49.2M Buy
+2,270,520
New +$49.2M 0.31% 80